Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


This article was originally published in The Tan Sheet

Executive Summary

Net revenue rose 56.9% to $8 mil. in fourth quarter and 302.2% to $36.2 mil. for year, says Feb. 22 after announcing plans to discontinue OTC health and beauty Feb. 12 (1"The Tan Sheet" Feb. 19, p. 9). Net loss was $176 mil. in quarter, down 70.9%, and $303.6 mil. in 2000, down 209.8%, including non-cash and non-recurring charges. Negative cash flow is expected to continue into 2001 and firm is taking steps to liquidate its distribution center and other assets. A conference call scheduled for Feb. 21 when the firm was expected to announce a new specialty pharmacy business partner was postponed

You may also be interested in... Third Quarter Break-Even Predicted's operations will break even before October, Chairman and CEO Albert Greene predicted in a Feb. 14 analysts call.

People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts